Citation & Authors
Antioxidants (Basel). 2025;14(8):1016.
ABSTRACT · CHINESE TRANSLATION
Translated abstract
Translated from the licensed abstract via the Chinese version. This is not an official journal translation.
Summary
Oxidative stress plays an important role in cataract formation. Melatonin is an endogenous hormone thought to counter oxidative stress, but its association with cataract risk remains uncertain. This target trial emulation used TriNetX electronic health records from 2015–2023 to investigate melatonin use and cataract risk. Adults aged ≥40 years with a sleep disorder who initiated melatonin or a benzodiazepine (BZD) hypnotic were included, with BZD users as active comparators. Propensity score matching controlled covariates, and exposure was defined as initiation of melatonin or a BZD hypnotic. Primary outcomes were age-related cataract and other cataract types. Cox proportional hazards models estimated HRs and 95% confidence intervals, and subgroup and sensitivity analyses addressed potential bias. Matching yielded 5,507 patients per group. Compared with BZD users, melatonin users had significantly lower risks of age-related cataract (HR 0.741; 95% CI 0.681–0.807) and other cataracts (0.503; 0.433–0.584), with consistent findings across subgroups and sensitivity analyses. The study found an association between melatonin use and lower cataract risk; its potential protective effect warrants further investigation.
Original work: Author of the above paper. Source:Public Summary ↗. This translation is based on the Chinese rendering of the original English abstract.
Original work license:CC BY ↗;Translations are subject to the same licensing conditions.
